Determinants of Urine Output Using Advanced Hemodynamic Monitoring in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

被引:0
|
作者
Bitker, Laurent [1 ,2 ,3 ]
Biscarrat, Charlotte [1 ]
Yonis, Hodane [1 ]
Chivot, Matthieu [1 ]
Chauvelot, Louis [1 ]
Chazot, Guillaume [1 ]
Mezidi, Mehdi [1 ]
Deniel, Guillaume [1 ,2 ,3 ]
Richard, Jean-Christophe [1 ,2 ,3 ]
机构
[1] Hosp Civils Lyon, Hop Croix Rousse, Serv Med Intens Reanimat, Lyon, France
[2] Univ Lyon, Univ Claude Bernard Lyon 1, INSA Lyon, CNRS,INSERM, F-69621 Villeurbanne, France
[3] Univ Claude Bernard Lyon 1, Univ Lyon, Villeurbanne, France
关键词
Continuous renal replacement therapy; Acute kidney injury; Urine output; Net ultrafiltration; Acute circulatory failure; Cardiac output; Preload dependence; Pulse-contour; GLOMERULAR-FILTRATION-RATE; ACUTE KIDNEY INJURY; GUIDELINES; FLOW;
D O I
10.1159/000535544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Low cardiac output and hypovolemia are candidate macrocirculatory mechanisms explanatory of de novo anuria in intensive care unit (ICU) patients undergoing continuous renal replacement therapy (CRRT). We aimed to determine the hemodynamic parameters and CRRT settings associated with the longitudinal course of UO during CRRT. Methods: This is an ancillary analysis of the PRELOAD CRRT observational, single-center study (NCT03139123). Enrolled adult patients had severe acute kidney injury treated with CRRT for less than 24 h and were monitored with a calibrated continuous cardiac output monitoring device. Hemodynamics (including stroke volume index [SVI] and preload-dependence, identified by continuous cardiac index variation during postural maneuvers), net ultrafiltration (UFNET), and UO were reported 4-hourly, over 7 days. Two study groups were defined at inclusion: non-anuric participants if the cumulative 24 h UO at inclusion was >= 0.05 mL kg(-1) h(-1), and anuric otherwise. Quantitative data were reported by its median [interquartile range]. Results: Forty-two patients (age 68 [58-76] years) were enrolled. At inclusion, 32 patients (76%) were not anuric. During follow-up, UO decreased significantly in non-anuric patients, with 25/32 (78%) progressing to anuria within 19 [10-50] hours. Mean arterial pressure (MAP) and UFNET did not significantly differ between study groups during follow-up, while SVI and preload-dependence were significantly associated with the interaction of study group and time since inclusion. Higher UFNET flow rates were significantly associated with higher systemic vascular resistances and lower cardiac output during follow-up. Multivariate analyses showed that (1) lower UO was significantly associated with lower SVI, lower MAP, and preload-independence; and (2) higher UFNET was significantly associated with lower UO. Conclusions: In ICU patients treated with CRRT, those without anuria showed a rapid loss of diuresis after CRRT initiation. Hemodynamic indicators of renal perfusion and effective volemia were the principal determinants of UO during follow-up, in relation with the hemodynamic impact of UFNET setting.
引用
收藏
页码:189 / 199
页数:11
相关论文
共 50 条
  • [1] Echinocandin Dosing in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Aguilar G.
    Ferriols R.
    Navarro D.
    Belda F.J.
    Current Fungal Infection Reports, 2017, 11 (1) : 1 - 4
  • [2] Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Krueger, Chelsea K.
    Bruno, Jeffrey J.
    Tverdek, Frank P.
    Hernandez, Mike
    Abudayyeh, Ala
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (06) : 629 - 636
  • [3] Daptomycin pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
    Rudiger, Alain
    Rentsch, Katharina
    Maggiorini, Marco
    Corti, Natascia
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1243 - 1244
  • [4] Continuous renal replacement therapy in critically ill patients: Monitoring circuit function
    Holt, AW
    Bierer, P
    Bersten, AD
    Bury, LK
    Vedig, AE
    ANAESTHESIA AND INTENSIVE CARE, 1996, 24 (04) : 423 - 429
  • [5] Continuous renal replacement therapy in critically ill patients
    Ronco, C
    Bellomo, R
    Ricci, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 67 - 72
  • [6] Norepinephrine and Hospital Mortality in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Chou, Che-Yi
    Yeh, Hung-Chieh
    Chen, Wei
    Liu, Jiung-Hsiun
    Lin, Hsin-Hung
    Liu, Yao-Lung
    Yang, Ya-Fei
    Wang, Shu-Ming
    Huang, Chiu-Ching
    ARTIFICIAL ORGANS, 2011, 35 (02) : E11 - E17
  • [7] Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Song, Shuping
    Liu, Jieqiong
    Su, Wei
    Yu, Haitao
    Feng, Binbin
    Wu, Yinshan
    Guo, Feng
    Yu, Zhenwei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 4459 - 4469
  • [8] Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy
    Kalaria, Shamir
    Williford, Sarah
    Guo, Dong
    Shu, Yan
    Medlin, Christopher
    Li, Matthew
    Yeung, Siu Yan Amy
    Ali, Farhan
    Jean, Wisna
    Gopalakrishnan, Mathangi
    Heavner, Mojdeh
    PHARMACOTHERAPY, 2021, 41 (02): : 205 - 211
  • [9] Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Arantxazu Isla
    Alicia Rodríguez-Gascón
    Iñaki F. Trocóniz
    Lorea Bueno
    María Ángeles Solinís
    Javier Maynar
    José Ángel Sánchez-Izquierdo
    José Luis Pedraz
    Clinical Pharmacokinetics, 2008, 47 : 173 - 180
  • [10] Daptomycin pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy reply
    Vilay, A. Mary
    DePestel, Daryl D.
    Mueller, Bruce A.
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1244 - 1245